Back to Directory

Alexamorelin

Growth Hormone Secretagogues

GHRP investigated for frailty and growth hormone deficiency.

Key Benefits

  • ✓GH stimulation
  • ✓Investigated for frailty

Dosing Information

Dosage Range
Research stage
Frequency
Discontinued
Typical Duration
N/A

Detailed Protocol

Development discontinued.

About Alexamorelin

Alexamorelin is a synthetic GHRP that was studied for treatment of frailty in elderly patients and growth hormone deficiency. Clinical development appears discontinued.

Research Notes

Clinical trials conducted but development not continued. Another GHRP that didn commercially succeed.

Get Peptide Research Updates

Newsletter signup

Please wait...

Thanks for signing up! You will receive an email to confirm your subscription.

Potential Side Effects

  • •Development discontinued

Always consult with a healthcare professional before starting any peptide therapy.